Login
TELEFLEX INC logo

TELEFLEX INC

teleflex.com

What Do They Do?

Sells single-use medical devices for vascular access, interventional procedures and surgery to hospitals and healthcare providers.

How Do They Make Money?

Hospitals, healthcare providers and distributors pay for medical devices when they ship; payment is generally due 30 days after invoicing.

revenue
SegmentShareRevenue
Vascular Access
Sold outright

46%
FY2022: 24%
Interventional
Sold outright

33%
FY2022: 16%
Surgical
Sold outright

21%
FY2022: 14%
Other
0.5%
FY2022: 10%

Who Are Their Customers?

Hospitals and healthcare providers buy through Teleflex's direct sales force or distributors; sales also go directly to distributors through its sales force, independent representatives and distributor networks.

Do Revenues Turn Into Profits?

No. It lost $905.6M in FY2025.

Operating income, FY2025
6% of revenue
▲ +14% vs FY2024 ($103.7M, 6%)
Net income, FY2025
−45% of revenue
▼ Turned to a loss vs FY2024 ($69.7M, 4%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ 0%
vs $566.9M in Q3 FY2025
Net income
▲ Turned profitable
vs −$408.9M in Q3 FY2025
  • Aug 6, 2026 Teleflex lowered revenue guidance and raised adjusted earnings guidance It lowered revenue-growth and GAAP earnings ranges while raising adjusted diluted earnings per share guidance.
  • Aug 3, 2026 Teleflex completed the sale of its OEM business It sold the OEM business to Lotus US Bidco Inc. for cash.

Shrinking. Revenue fell 29% in 4 years, from $2.8B in FY2021 to $2B in FY2025, about 8% a year.

Expanded interventional range Teleflex added drug-coated balloons, stents and balloon catheters through its acquisition of BIOTRONIK's Vascular Intervention business, alongside its existing coronary and peripheral products.

OEM business planned for sale The older report described OEM as a reportable segment supplying devices to medical-device makers; the latest report includes OEM among the businesses Teleflex plans to sell.

Revenue over time
Vascular Access Interventional Surgical Other Anesthesia Interventional urology OEM
$5B$2.5B$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support